IGF-1 LR3

IGF-1 LR3 Storage: A Folded Protein, Not a Peptide

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

IGF-1 LR3 is a folded protein held by three disulfide bonds, and its principal vulnerability is loss of structure rather than chemical degradation. It can become inactive while remaining chemically intact. A failure mode short peptides do not have.

Key facts

Class
Folded protein, 83 residues
Main risk
Denaturation, not chemistry
Detectable by MS
No (mass is unchanged)
Disulfide scrambling
Possible, also mass-invisible
Adsorption
Significant at low concentrations
Freeze-thaw
Particularly damaging

The failure mode that has no peptide equivalent

KPV is three residues with no structure to lose. It is either chemically intact or it is not. A folded protein has a third state: chemically perfect and biologically inert, because the fold has been lost. No mass measurement detects this, and no purity figure describes it.

Why interfaces are the enemy

Proteins unfold at air-liquid interfaces, where the hydrophobic core that folding buries becomes exposed. Shaking creates interface; foaming is visible evidence of it. Once unfolded, a protein tends to aggregate with others, and aggregation is not reversible by remixing.

Research material referenced

IGF-1 LR3 1mg, third-party HPLC tested

Buy IGF-1 LR3 · £49.99

Disulfide scrambling

Three disulfide bonds can, under the right conditions, exchange partners, producing a molecule with identical composition and mass but the wrong connectivity and the wrong shape. Elevated pH and the presence of free thiols promote this. It is another route to an inactive product that looks perfect analytically.

Adsorption at low concentrations

Proteins bind to glass and plastic, and at the microgram quantities this compound is used in, surface losses can be a significant fraction of the material. Carrier protein in the buffer is the standard mitigation for exactly this reason, along with low-binding consumables and minimal transfer steps.

Freeze-thaw

Worse for a folded protein than for a short peptide. Ice formation concentrates solutes at the advancing boundary, shifts local pH, and creates new interfaces on every cycle. Aliquot into single-use volumes before freezing rather than cycling a stock.

What follows from all of this

A certificate confirming mass and purity does not confirm that a protein preparation is active. For a compound whose function depends entirely on a fold, that is a real limitation of the standard documentation.

Frequently asked questions

Can IGF-1 LR3 be inactive but chemically intact?

Yes. Loss of fold produces an inactive protein with unchanged mass and composition. This has no equivalent in a short peptide.

Why does adsorption matter?

At the microgram quantities used, protein binding to glass and plastic can be a significant fraction of the material.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More IGF-1 LR3 articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.